Recalls for Atracurium Besylate Injection

Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
02/24/2015 Medical Recall

Has the potential to result in infections, which could be fatal, especially in patients who are immunocompromised.

  • Company:
    Atracurium Besylate Injection